gms | German Medical Science

31. Internationaler Kongress der Deutschen Ophthalmochirurgen (DOC)

14.06. - 16.06.2018, Nürnberg

Artikel

Artikel empfehlen

“Same day” vitrectomy to treat endophthalmitis in the course of anti-VEGF treatment for AMD can save the eye and restore visual acuity

Meeting Abstract

Suche in Medline nach

  • Zofia Michalewska - Ophthalmic Clinic Jasne Blonia, Lodz, Polen
  • Karolina Boninska - Ophthalmic Clinic Jasne Blonia, Lodz, Polen
  • Jerzy Nawrocki - Ophthalmic Clinic Jasne Blonia, Lodz, Polen

31. Internationaler Kongress der Deutschen Ophthalmochirurgen. Nürnberg, 14.-16.06.2018. Düsseldorf: German Medical Science GMS Publishing House; 2018. DocWK 3.8

doi: 10.3205/18doc089, urn:nbn:de:0183-18doc0895

Veröffentlicht: 13. Juni 2018

© 2018 Michalewska et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.

Gliederung

Text

Goal: To present effects of long-term anti-VEGF (Vascular Endothelial Growth Factor) treatment in eyes after vitrectomy for endophthalmitis in neovascular age related macular degeneration.

Methods: Core vitrectomy, with intravitreal vancomycin was performed. Spectral domain optical coherence tomography was performed monthly both before and after surgery in the follow- up mode. Anti-VEGF injections were continued after surgery.

Results: Eight eyes were included in this study. Final mean visual acuity at the end of follow up (12-84 months) was statistically indifferent from visual acuity on the visit just before endophthalmitis (p=0.69). The mean frequency of injections after surgery did not significantly differ from the presurgical scheme of treatment (p=0.97).

Conclusion: Early vitrectomy for endophthalmitis enables continuation of anti-VEGF injections and does not influence the frequency of injections. This treatment results in satisfactory visual acuity in the long term. Early intervention is safe and might be recommended even for patients with visual acuity better than light perception.